Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001085794 | SCV000627267 | benign | Osteogenesis imperfecta type I | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000610149 | SCV000730942 | benign | not specified | 2017-07-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000710773 | SCV000841076 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000710773 | SCV001477907 | benign | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002330828 | SCV002631774 | benign | Cardiovascular phenotype | 2019-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000610149 | SCV001977655 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000710773 | SCV001978410 | likely benign | not provided | no assertion criteria provided | clinical testing |